GZMA and neoplasm: Tumor CD8+ cells (representing CD8+ T cells) and CD57+ cells (representing NK cells) downregulated pyroptosis expression percentage, especially GZMA+ and GSDMB+, acting as a protective prognostic predictor clinically.